组织蛋白酶
组织蛋白酶B
组织蛋白酶L
癌症研究
细胞培养
肿瘤进展
组织蛋白酶
细胞生长
转基因小鼠
生物
增生
分子生物学
癌症
转基因
内分泌学
酶
生物化学
基因
遗传学
作者
Stefanie Mullins,Mansoureh Sameni,Galia Blum,Matthew Bogyo,Bonnie F. Sloane,Kamiar Moin
标识
DOI:10.1515/hsz-2012-0252
摘要
The expression of the cysteine protease cathepsin B is increased in early stages of human breast cancer.To assess the potential role of cathepsin B in premalignant progression of breast epithelial cells, we employed a 3D reconstituted basement membrane overlay culture model of MCF10A human breast epithelial cells and isogenic variants that replicate the in vivo phenotypes of hyper plasia(MCF10AneoT) and atypical hyperplasia (MCF10AT1). MCF10A cells developed into polarized acinar structures with central lumens. In contrast, MCF10AneoT and MCF10AT1 cells form larger structures in which the lumens are filled with cells. CA074Me, a cell-permeable inhibitor selective for the cysteine cathepsins B and L,reduced proliferation and increased apoptosis of MCF10A, MCF10AneoT and MCF10AT1 cells in 3D culture. We detected active cysteine cathepsins in the isogenic MCF10 variants in 3D culture with GB111, a cell-permeable activity based probe, and established differential inhibition of cathepsin B in our 3D cultures. We conclude that cathepsin B promotes proliferation and premalignant progression of breast epithelial cells. These findings are consistent with studies by others showing that deletion of cathepsin B in the transgenic MMTV-PyMT mice, a murine model that is predisposed to development of mammary cancer, reduces malignant progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI